Phase 2 data demonstrate differentiated CXCR4 inhibition kinetics enabling same-day cell collection, with rapid lymphocyte mobilization supporting potential therapeutic applications beyond transplant ...
Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...
The idea of diagnosing Alzheimer’s with a quick, finger-prick test marks a profound shift in how we could approach ...
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
TikTok's new terms (22 Jan 2026) alarm users with a pop-up on data collection, revealing it may gather sensitive info like ...
A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...
Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it will present a poster at the upcoming 2026 Tandem ...
New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive worsening at 78 weeks with ...
Background: Liquid biopsy using circulating tumor DNA (ctDNA) has emerged as a promising tool for molecular characterization and monitoring in gliomas. This systematic review and meta-analysis ...
Doug Bihlmaier, a hero to style influencers, is parting with rare jackets, boots, belts and workwear items. By Steven Kurutz Selling off someone’s personal closet with fanfare is usually reserved for ...
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. Built on Alamar's proprietary NULISA™ platform, the NULISAqpcr BD-pTau217 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results